Researchers at Stanford University have demonstrated rapid and accurate identification of extracellular vesicles (EVs) from different cell lines using an AI-assisted optical platform.
Stanford scientists have developed a device to distinguish the molecule-specific signatures of diseased exosomes isolated from glioblastoma patients. The device is portable, disposable, and low-cost, enabling point-of-care assessment of disease.